Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPA1 | P15085 | 8/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | ALPI | P09923 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.46 |
| ▸ | XIAP | P98170 | 1/20 | 0.46 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.46 |
| ▸ | ADAMTS5 | Q9UNA0 | 2/20 | 0.44 |
| ▸ | CPA3 | P15088 | 2/20 | 0.43 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.43 |
| ▸ | CPB1 | P15086 | 1/20 | 0.43 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.43 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.42 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.42 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.42 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL598437 | 1.00 | CPA1 (0.54) | CPA1CYP1A2ALPIPKMPTGS1 | |
| SCHEMBL432795 | 0.87 | SLC7A5 (0.49) | CPA1SLC7A5FOLH1 | |
| SCHEMBL432794 | 0.87 | SLC7A5 (0.49) | CPA1SLC7A5FOLH1 | |
| SCHEMBL6013489 | 0.83 | CPA1 (0.51) | CPA1CYP1A2ALPIPKMPTGS1 | |
| SCHEMBL6013488 | 0.83 | CPA1 (0.51) | CPA1CYP1A2ALPIPKMPTGS1 | |
| SCHEMBL16735767 | 0.81 | CPA1 (0.49) | CPA1CYP1A2ALPIPKMPTGS1 | |
| SCHEMBL599387 | 0.80 | TSHR (0.46) | CYP1A2 | |
| SCHEMBL9614485 | 0.79 | CPA1 (0.47) | CPA1CYP1A2ALPIPKMPTGS1 | |
| SCHEMBL20856984 | 0.76 | FNTA (0.47) | CPA1SLC7A5 | |
| SCHEMBL7364031 | 0.76 | CPA1 (0.44) | CPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8114648-B2 | In vivo incorporation of unnatural amino acids | THE SCRIPPS RESEARCH INSTITUTE (US) | 2012-02-14 | — | — | US | claimed |
| US-20080167243-A1 | immunizing a subject with a sufficient amount of a translated polypeptide to produce antibody; containing a phenylalanine or tyrosine derivative analoges | THE SCRIPPS RESEARCH INSTITUTE | 2008-07-10 | — | — | US | claimed |
| EP-1154802-A1 | METHOD OF MEASURING PHYSIOLOGICAL FUNCTION | Mallinckrodt Inc. (US) | 2001-11-21 | — | — | EP | claimed |
| WO-2000050093-A1 | METHOD OF MEASURING PHYSIOLOGICAL FUNCTION | MALLINCKRODT INC. (US) | 2000-08-31 | — | — | WO | claimed |
| CN-115160425-A | Rice mutant protein with high dinitroaniline herbicide resistance and corresponding gene | 安徽省农业科学院水稻研究所 | 2022-10-11 | — | — | CN | disclosed |
| CN-114989282-A | Rice mutant protein resisting dinitroaniline herbicide and application thereof | 安徽省农业科学院水稻研究所 | 2022-09-02 | — | — | CN | disclosed |
| CN-114540374-A | High-herbicide-resistance plant gene mutant and corresponding vector and application | 安徽农业大学 | 2022-05-27 | — | — | CN | disclosed |
| CN-114478731-A | Herbicide-resistant rice mutant protein and application thereof | 安徽农业大学 | 2022-05-13 | — | — | CN | disclosed |
| US-20080051317-A1 | Polypeptides comprising unnatural amino acids, methods for their production and uses therefor | CODON DEVICES, INC. | 2008-02-28 | — | — | US | disclosed |
| WO-2007075438-A2 | POLYPEPTIDES COMPRISING UNNATURAL AMINO ACIDS, METHODS FOR THEIR PRODUCTION AND USES THEREFOR | CODON DEVICES, INC. (US) | 2007-07-05 | — | — | WO | disclosed |
| EP-1192458-B1 | OPTICAL SENSOR FOR POTASSIUM IONS | ANDREAE FRITZ (AT) | 2003-04-16 | — | — | EP | disclosed |
| EP-1192458-A1 | OPTICAL SENSOR FOR POTASSIUM IONS | Andreae, Fritz (AT) | 2002-04-03 | — | — | EP | disclosed |
| EP-1154802-A1 | METHOD OF MEASURING PHYSIOLOGICAL FUNCTION | Mallinckrodt Inc. (US) | 2001-11-21 | — | — | EP | disclosed |
| WO-2001004623-A1 | OPTICAL SENSOR FOR POTASSIUM IONS | ANDREAE FRITZ (AT) | 2001-01-18 | — | — | WO | disclosed |
| WO-2000050093-A1 | METHOD OF MEASURING PHYSIOLOGICAL FUNCTION | MALLINCKRODT INC. (US) | 2000-08-31 | — | — | WO | disclosed |
| EP-0900272-A2 | TUMOR NECROSIS FACTOR ALPHA CONVERTASE | GLAXO GROUP LIMITED (GB) | 1999-03-10 | — | — | EP | disclosed |
| WO-1997035538-A2 | TUMOR NECROSIS FACTOR ALPHA CONVERTASE | GLAXO GROUP LIMITED (GB) | 1997-10-02 | — | — | WO | disclosed |
| US-4438030-A | Antibodies to immunogenic peptides and their use to purify human fibroblast interferon | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1984-03-20 | — | — | US | disclosed |
| US-4341761-A | Antibodies to immunogenic peptides and their use to purify human fibroblast interferon | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1982-07-27 | — | — | US | disclosed |
| US-4311639-A | Immunogenic interferon peptides | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1982-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080167243-A1 | immunizing a subject with a sufficient amount of a translated polypeptide to produce antibody; containing a phenylalanine or tyrosine derivative analoges | DNPEP, NPEPPS, TYR | CPA1 734/4885CYP1A2 4625/4885ALPI 3704/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.